Asia Business News | Sunday, May 18, 2008
email news alerts
RSS 2.0  
Development of diagnostics, pharmaceuticals and treatments for diabetes.
Company Fax (03) 8862 6610 
Company Principal Sector Health & Pharm 
Company Principal Industry Biotechnology 
Company Listed 2005/01/24 
Company Homepage www.dia-btech.com.au
 
Stock Exchange Stock Code
ASXDIA
News Reader RSS   DIA-B TECH LIMITED
Drag Podcast Icon To iTunes - Podcast Download for DIA-B TECH LIMITED
 Dia-b Tech Limited ASX: DIA - Human Clinical Trials - Mr Ken Smith, CEO (DEC 4, 2006)